Omeros CORP Form 4 insider transactions

Gregory A Demopulos, Chairman, CEO & President and a Director of Omeros Corp, received 1,000,000 shares of common stock on July 22, 2026.

Peter B Cancelmo, VP, General Counsel of Omeros Corp, received 105,000 shares of common stock on July 22, 2026.

David J. Borges, VP, Finance & CAO of Omeros Corp, received 105,000 shares of common stock on July 22, 2026.

Director Thomas J. Cable exercised 7,500 stock options and sold the resulting shares under a pre-established Rule 10b5-1 plan.

Omeros Corp's Chairman, CEO, and President, Gregory A. Demopulos, MD, exercised 400,000 stock options and settled associated tax liabilities through a net share settlement on February 18, 2026.

Omeros Corp's VP of Finance and CAO, David J. Borges, reported the sale of 60,000 common shares following the exercise of stock options.

Omeros Corp's Chairman, CEO, and President, Gregory A. Demopulos, MD, gifted 600,000 shares of common stock to irrevocable trusts for his minor children.

Omeros Corp's Chairman, CEO, and President, Gregory A. Demopulos, MD, was granted 865,000 stock options with an exercise price of $3.2 per share, vesting over 48 months.

Omeros Corp has granted 100,000 stock options to Peter B. Cancelmo, VP and General Counsel, with an exercise price of $3.20 per share, vesting over 48 months.

Omeros Corp has granted 95,000 stock options to David J. Borges, VP of Finance & CAO, with an exercise price of $3.20 per share and a ten-year expiration.

Omeros Corporation's Director, Rajiv Shah, was granted an option to purchase 15,000 shares of common stock at an exercise price of $3.20 per share, pursuant to the company's non-employee director compensation policy.

Omeros Corporation Director Diana T. Perkinson was granted 15,000 stock options as part of the company's non-employee director compensation policy.

Omeros Corporation's Director, Dr. Leroy E. Hood, was granted 15,000 stock options as part of the company's non-employee director compensation policy, exercisable at $3.2 per share.

Omeros Corporation's Director, Arnold C. Hanish, received an annual grant of 15,000 stock options with an exercise price of $3.20 per share, vesting in 2026.

Omeros Corporation's Director, Peter A. Demopulos MD, was granted an option to purchase 15,000 shares of common stock at an exercise price of $3.2 per share, pursuant to the company's non-employee director compensation policy.

Omeros Corporation Director Thomas J. Cable was granted 15,000 stock options with an exercise price of $3.20 per share as part of the company's non-employee director compensation policy.

Omeros Corporation's Director, Thomas F. Bumol, was granted 15,000 stock options with an exercise price of $3.20 per share as part of the company's non-employee director compensation policy.

Director Rajiv Shah was granted a stock option to purchase 15,000 shares of Omeros Corporation common stock on June 6, 2024, as part of the company's non-employee director compensation policy.

Director Diana T. Perkinson receives a stock option to purchase 15,000 shares of Omeros Corp common stock as part of the company's non-employee director compensation policy.

Director Leroy E. Hood receives a stock option to purchase 15,000 shares of Omeros Corp common stock as part of the company's non-employee director compensation policy.

Director Arnold C Hanish acquired 15,000 shares of Omeros Corp through a stock option grant on June 6, 2024, as part of the company's non-employee director compensation policy.

Director Peter Demopulos received a stock option to purchase 15,000 shares of Omeros Corp common stock on June 6, 2024, as part of the company's non-employee director compensation policy.

Director Thomas J. Cable received a stock option to purchase 15,000 shares of Omeros Corp common stock on June 6, 2024, as part of the company's non-employee director compensation policy.

Director Thomas F. Bumol was granted a stock option to purchase 15,000 shares of Omeros Corp common stock on June 6, 2024, as part of the company's non-employee director compensation policy.

Gregory A. Demopulos, Chairman, CEO, and President of Omeros Corp, acquired 725,000 stock options on April 25, 2024, exercisable over 48 months.

Michael A. Jacobsen, VP, Finance & CAO of Omeros Corp, reports the acquisition of 100,000 stock options at an exercise price of $3.06, vesting monthly over four years.

VP, General Counsel of Omeros Corp, Peter B. Cancelmo, reports the acquisition of stock options.